NYC 9/11 Public Portal Document
4 ’ iPi 4 V r 5 ® *2
nym
NEW YOR^METHODIST HOSPITAL
Medical and Public Health Issues Raised by
the Attack on the World Trade Center
Risk of Bioterrorism
According to the New York City Department of Health (NYCDOH), the successful use of a
biological weapon is unlikely because a high level of technical sophistication would be required
to develop, maintain, transport and disperse biological agents.
Germ Warfare Surveillance
The NYCDOH has been actively monitoring for evidence of a bioterrorist attack.
Hospitals throughout New York City are monitoring for illness syndromes that would likely
occur if a biological pathogen were released in New York City. Any clustering increase of a
particular disease syndrome would be investigated immediately by Epidemic Intelligence Service
officers from the Centers for Disease Control and Prevention (CDC). To date, no unusual
disease clusters or manifestations suggestive of bioteirorism have been identified.
City Agency Response in the Event of a Bioterrorist Attack
If a bioterrorist attack took place, the NYCDOH would rapidly notify the medical
community with recommendations on diagnosis, treatment and preventative measures. In
addition, the CDC has developed a large national stockpile of pharmaceuticals, including
antibiotics that are effective against the most likely bioterrorist substances. This reserve of
pharmaceuticals would be swiftly delivered in the event of a bioterrorist attack. In fact, as a
precautionary measure, these pharmaceuticals were available in New York City within hours of
the attack on September 11*.
NYC-WTC_000149330
OCR can misread numbers and units. Confirm readings against the page image before using them.